The Food and Drug Administration and National Institutes of Health held a joint workshop July 7 on reducing animal testing in research, strikingly announcing that “NIH will no longer seek proposals ...
Animal models have long shaped how biomedical research is conducted. They have influenced how diseases are studied, how risks are assessed, and how potential treatments move from early discovery ...
For decades, the pharmaceutical industry has discussed moving away from in vivo models in preclinical research. Now, it’s more than a conversation. The FDA’s roadmap for reducing animal testing, ...
New grants support organoids, organs-on-chips, and in silico approaches to reduce reliance on animal models, but experts say ...
It wasn’t just a favorite childhood pet, or the fact that she cares deeply for animals, that led Nicole Kleinstreuer to help launch the National Institutes of Health’s initiative to scale back ...
A social media post from the US Food and Drug Administration this week shows a big-eyed macaque staring out from behind bars. “Some drugs use 144 monkeys on average for preclinical testing,” the post ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results